Cite

HARVARD Citation

    Dhakal, A. et al. (2021). Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?. Cancer. 127 (18), pp. 3302-3309. [Online]. 
  
Back to record